NCT04646109 - Ivermectin for Severe COVID-19 Management | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

September 2, 2020

Study Completion Date

September 2, 2020

Conditions

COVID-19

Interventions

DRUG

Ivermectin

"Ivermectin 5mg/5ml solution was manufactured by NEUTEC™ Pharmaceutical Company-Turkey, under Good Manufacturing Practices (GMP) certification conditions."

Trial Locations (4)

Unknown

Afyonkarahisar Health Science University, Afyonkarahisar

Gulhane Faculty of Medicine, University of Health Sciences, Ankara

Yıldırım Beyazıt University, Ankara City Hospital, Ankara

Haydarpasa Sultan Abdulhamid Han Training and Research Hospital, Istanbul